Clinical trials
Pulmonary Embolism and Thrombosis clinical trials
Below are recruiting pulmonary embolism and thrombosis clinical trials, each written for real people, not researchers. We’re tracking 35 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06480994Recruiting
Testing a new tool to help diagnose blood clots
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
Niort, SartresAges 18 years+ - NCT06581965RecruitingPhase 4
Personalized blood clot prevention for hip or knee replacement
This trial compares a personalized approach to preventing blood clots after hip or knee replacement surgery with the standard one-size-fits-all method. The goal is to see if tailoring prevention to each patient works better and is safer.
Apeldoorn, GelderlandAges 18 years+ - NCT04731558RecruitingPhase 4
Blood clot prevention before versus after liver surgery
This study compares two approaches to preventing blood clots around the time of liver surgery. If you’re having planned liver surgery, it may help doctors choose the safest timing and method for clot prevention.
HelsinkiAges 18 years+ - NCT05881798Recruiting
Vena cava filter data study for specific filter type
This study checks outcomes and safety using real-world health data from people who received a specific type of vena cava filter. It may help improve future care by understanding how these devices perform after placement.
Los Angeles, CaliforniaAges 18 years+ - NCT06451003Recruiting
Preventing blood clots after cancer surgery: a program trial
This trial tests a program to help people who had cancer surgery get medicine to prevent dangerous blood clots. If you had belly or pelvic cancer surgery and are not on blood thinners, you may be able to join.
Charleston, South CarolinaAges 18 years+ - NCT06833827Recruiting
Clot removal vs clot-busting drugs for severe lung clots
This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.
Leiden, South HollandAges 18 years+ - NCT04211181Recruiting
Prevent blood clots in hospitalized teens and adults
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
Beijing, Beijing MunicipalityAges 14 years+ - NCT06753786Recruiting
Blood thinner timing study for bleeding stroke patients
This study looks at when it is safest to start blood thinners to prevent blood clots (deep vein thrombosis) after a type of bleeding stroke called hypertensive intracerebral hemorrhage. Researchers want to find the best time to start this prevention treatment.
MoscowAges 18 years+ - NCT06194617Recruiting
Rivaroxaban for older Chinese patients with blood clots in lungs
This trial tests whether a blood thinner called rivaroxaban (a pill) works well for older Chinese patients who have had a blood clot in their lungs and are now on long-term treatment. It aims to see if it's safe and effective for this group.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06362343Recruiting
Personalized dosing study for Xa inhibitor blood thinners
This study looks at how the body processes a certain type of blood thinner (Xa factor inhibitors) to help doctors find the right dose for each person. If you have a blood clot in your lungs and are on long-term treatment, this trial might help improve your care.
Beijing, Beijing MunicipalityAges 18–120 - NCT07102160Recruiting
Long-term safety and effectiveness of the Cleaner Vac system for blood clots
This study tracks how well the Cleaner Vac® system works to remove blood clots from leg veins over time. It may be an option for people with new or recent deep vein thrombosis (DVT) who are getting their first treatment.
Fort Lauderdale, FloridaAges 18 years+
Hear when a new Pulmonary Embolism and Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary embolism and thrombosis?
- Yes. Clin2 currently lists 35 recruiting pulmonary embolism and thrombosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary embolism and thrombosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary embolism and thrombosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.